Eli Lilly has shown patients…
Eli Lilly has shown patients maintained most of their weight [...]
GSK is embarking on a journey with…
GSK is embarking on a journey with CAMP4 Therapeutics, paying [...]
Takeda’s closely watched and…
Takeda’s closely watched and highly valued dermatology pill zasocitinib has [...]
Bristol Myers Squibb has become…
Bristol Myers Squibb has become the latest Big Pharma to [...]
University of California spinout…
University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” [...]
Nektar Therapeutics is planning to…
Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate [...]
Sanofi is back with its second…
Sanofi is back with its second pact of the day, [...]
MapLight Therapeutics is the…
MapLight Therapeutics is the latest biotech to want a turn [...]
Aviceda Therapeutics has hit a…
Aviceda Therapeutics has hit a snag in its goal to [...]
Fresh off a $153 million series E…
Fresh off a $153 million series E round, Arthrosi Therapeutics [...]